ZELBORAF®: ZELBORAF® = vemurafenib. "kinase inhibitor indicated for the treatment of patients with unresectable or metastatic melanoma with BRAF V600E mutation as detected by an FDA-approved test" See: http://www.gene.com/download/pdf/zelboraf_prescribing.pdf
Answered 5/9/2015
2.9k views
90,000 U.S. doctors in 147 specialties are here to answer your questions or offer you advice, prescriptions, and more.
Ask your question